statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex ), an innovative revenue-generating company focused on acquiring, developing and commercializing...

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Oramed Pharmaceuticals (ORMP, $3.24) Aroon Indicator entered an Uptrend on March 04, 2024.

Oramed Pharmaceuticals (ORMP, $3.43) Aroon Indicator entered an Uptrend on March 01, 2024.

Oramed Pharmaceuticals (ORMP, $3.28) Aroon Indicator entered an Uptrend on February 29, 2024.

This is a signal that ORMP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Oramed Pharmaceuticals (ORMP, $3.41) RSI Indicator left the overbought zone on February 28, 2024

Oramed Pharmaceuticals (ORMP, $3.41) Aroon Indicator entered an Uptrend on February 28, 2024.

Oramed Pharmaceuticals (ORMP, $3.57) Aroon Indicator entered an Uptrend on February 27, 2024.

Oramed Pharmaceuticals (ORMP, $3.55) Aroon Indicator entered an Uptrend on February 26, 2024.

Oramed Pharmaceuticals (ORMP, $3.3) RSI Indicator left the overbought zone on February 22, 2024

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Oramed Pharmaceuticals, Inc

Volume	64,697.00
52-Wk High	$5.25
52-Wk Low	$1.67

Period	Estimated	Reported	Surprise	Result
Q1'24	$0.02	--	--	N/A
Q4'23	-$0.12	--	--	N/A
Q3'23	-$0.09	--	--	N/A
Q2'23	-$0.10	--	--	N/A
Q1'23	-$0.08	--	--	N/A

ORMP Oramed Pharmaceuticals, Inc

About

Feed

News

Sentiment

Earnings

Fundamentals